R
7.49
-0.59 (-7.25%)
| Penutupan Terdahulu | 8.07 |
| Jumlah Dagangan | 336,671 |
| Harga / Jualan (P/S) | 2.92 |
| Harga / Buku (P/B) | 3.61 |
| Julat 52 Minggu |
| Margin Keuntungan | -100.62% |
| Margin Operasi (TTM) | 13.62% |
| EPS Cair (TTM) | -3.09 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 469.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 48.70% |
| Nisbah Semasa (MRQ) | 2.93 |
| Aliran Tunai Operasi (OCF TTM) | -84.04 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -56.82 M |
| Pulangan Atas Aset (ROA TTM) | -17.56% |
| Pulangan Atas Ekuiti (ROE TTM) | -47.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | REGENXBIO Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Nilai 35% | -0.4 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -0.4 |
| Masa 35% | 1.2 |
| AI Technical info | NA |
| Osilator Teknikal info | 2.0 |
| Purata Bergerak Teknikal info | 0.0 |
| Wang Pintar 30% | 1.4 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | 3.5 |
| Persekitaran | ×0.79 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -22.5% |
| Persetujuan Tonggak | ×1.11 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 0.4 |
| Skor Akhir | 0.61 |
|
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.70% |
| % Dimiliki oleh Institusi | 87.65% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Redmile Group, Llc | 30 Jun 2026 | 4,368,804 |
| Integral Health Asset Management, Llc | 30 Jun 2026 | 800,000 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CHAN MITCHELL | 7.20 | - | 24,305 | 174,996 |
| CHRISTMAS PATRICK J. | 7.20 | - | 34,722 | 249,998 |
| MALZAHN CRAIG | 7.20 | - | 27,777 | 199,994 |
| PAKOLA STEVE | 7.20 | - | 34,722 | 249,998 |
| Jumlah Keseluruhan Kuantiti Bersih | 121,526 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 874,987 | |||
| Purata Pembelian Keseluruhan ($) | 7.20 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CHAN MITCHELL | Pegawai | 01 Nov 2026 | Diperolehi (+) | 24,305 | 7.20 | 174,996 |
| PAKOLA STEVE | Pegawai | 01 Nov 2026 | Diperolehi (+) | 34,722 | 7.20 | 249,998 |
| CHRISTMAS PATRICK J. | Pegawai | 01 Nov 2026 | Diperolehi (+) | 34,722 | 7.20 | 249,998 |
| MALZAHN CRAIG | Pegawai | 01 Nov 2026 | Diperolehi (+) | 27,777 | 7.20 | 199,994 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |